Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | PDCD1 | Q15116 | 3/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.34 |
| ▸ | TOP2A | P11388 | 1/20 | 0.34 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37187 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL4546275 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL16018595 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL15280759 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL12168228 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL6438852 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL5695275 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL20671060 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL22227398 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL4943654 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11323309-A | — | — | None | — | — | JP | disclosed |
| CN-117412412-B | Graphene far infrared electrothermal film with rapid heat conduction and low energy consumption, and preparation method and application thereof | 江西省极热科技集团有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-117412412-A | Graphene far infrared electrothermal film with rapid heat conduction and low energy consumption, and preparation method and application thereof | 江西省极热科技集团有限公司 | 2024-01-16 | — | — | CN | disclosed |
| EP-2640791-B1 | ADHESIVE COMPOSITIONS AND USE THEREOF | Henkel IP & Holding GmbH (DE) | 2020-04-22 | — | — | EP | disclosed |
| US-8921464-B2 | Adhesive compositions and use thereof | Henkel US IP LLC (US) | 2014-12-30 | — | — | US | disclosed |
| US-20130184384-A1 | ADHESIVE COMPOSITIONS AND USE THEREOF | HENKEL CORPORATION (US) | 2013-07-18 | — | — | US | disclosed |
| US-7176325-B2 | Selective acylation of secondary hydroxyl groups | NATURAL PHARMACEUTICALS, INC. (US) | 2007-02-13 | — | — | US | disclosed |
| EP-1497275-A4 | SELECTIVE ACYLATION OF SECONDARY HYDROXYL GROUPS | NATURAL PHARMACEUTICALS INC (US) | 2006-04-12 | — | — | EP | disclosed |
| US-20050176975-A1 | Selective acylation of secondary hydroxyl groups | PHYTON HOLDINGS, LLC | 2005-08-11 | — | — | US | disclosed |
| US-20050077648-A1 | Solution casting method and polymer film | FUJIFILM CORPORATION (JP) | 2005-04-14 | — | — | US | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| JP-H11323309-A | GELLING AGENT COMPRISING SUGAR BENZYLIDENE DERIVATIVE | JAPAN SCIENCE & TECHNOLOGY CORP | 1999-11-26 | — | — | JP | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| EP-0456948-B1 | Method for the preparation of polyphosphorylated derivatives of galactopyranosides with a potential insulin-like activity | EUROPHARMA SA (ES) | 1995-08-30 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
| EP-0456948-A2 | Method for the preparation of polyphosphorylated derivatives of galactopyranosides with a potential insulin-like activity | EUROPHARMA, S.A. (ES) | 1991-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176975-A1 | Selective acylation of secondary hydroxyl groups | ABHD5, ABHD10, MOGAT2 | KMT2A 685/4885MEN1 2130/4885L3MBTL1 3716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.